News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Features Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers? Yael L. Maxwell August 02, 2019
News Features The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol Michael O'Riordan January 24, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Features Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent Caitlin E. Cox June 17, 2016